Regulatory T cell enhancement in adults with cystic fibrosis receiving Elexacaftor/Tezacaftor/Ivacaftor therapy

INTRODUCTION: Cystic fibrosis (CF), especially CF lung disease, is characterized by chronic infection, immune dysfunction including impairment of regulatory T cells (Tregs) and an exaggerated inflammatory response. CF transmembrane conductance regulator (CFTR) modulators have shown to improve clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Westhölter, Dirk, Raspe, Jonas, Uebner, Hendrik, Pipping, Johannes, Schmitz, Mona, Straßburg, Svenja, Sutharsan, Sivagurunathan, Welsner, Matthias, Taube, Christian, Reuter, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978140/
https://www.ncbi.nlm.nih.gov/pubmed/36875141
http://dx.doi.org/10.3389/fimmu.2023.1107437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978140/
https://www.ncbi.nlm.nih.gov/pubmed/36875141
http://dx.doi.org/10.3389/fimmu.2023.1107437

Ejemplares similares